The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Inhibrx Biosciences Announces Loan Agreement with Oxford Finance
Jan 13, 2025•over 1 year ago
Contract Type
agreement
San DiegoBiotechnologyTherapeuticsBiopharma
Description
Inhibrx Biosciences announced a five-year term loan facility for up to $150 million with Oxford Finance LLC. The loan provides strategic flexibility post data readouts expected later this year for their INBRX-109 and INBRX-106 programs.
Company Information
Company
Inhibrx
Location
11025 N. TORREY PINES ROAD, SUITE 200
San Diego, California, United States
About
Inhibrx is a clinical-stage biopharmaceutical company focused on developing a broad pipeline of novel biologic therapeutic candidates in oncology and orphan diseases. Inhibrx utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary protein engineering platforms.
San DiegoBiotechnologyTherapeuticsBiopharma